Eton Pharmaceuticals (ETON) Revenue Growth (1y) (2020 - 2025)
Eton Pharmaceuticals (ETON) Revenue Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.92% |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.11 Bn | 13.10 Mn | 82.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.72% |
| Sep 30, 2025 | 117.54% |
| Jun 30, 2025 | 108.60% |
| Mar 31, 2025 | 116.95% |
| Dec 31, 2024 | -60.92% |
| Sep 30, 2024 | 46.90% |
| Jun 30, 2024 | -24.36% |
| Mar 31, 2024 | 50.19% |
| Dec 31, 2023 | 250.69% |
| Sep 30, 2023 | 40.56% |
| Jun 30, 2023 | 139.94% |
| Mar 31, 2023 | 143.75% |
| Dec 31, 2022 | 39.47% |
| Sep 30, 2022 | 545.16% |
| Jun 30, 2022 | 63.03% |
| Mar 31, 2022 | -81.71% |
| Dec 31, 2021 | 203,200.00% |
| Sep 30, 2021 | 381.37% |
| Jun 30, 2021 | 15,235.00% |
| Mar 31, 2021 | 11,917.17% |